THE DATA BEHIND OUR NON-ADDICTIVE PRODUCT CANDIDATES
Jeffrey Gudin, M.D., Virpax’s Chief Medical Officer, has presented various posters on Virpax’s scientific advancements and discoveries.
A poster presented at the 2019 Military Health System Research Symposium (MHSRS) on August 21, 2019: Sustained Non-Opioid Pain Management in Prolonged Field Care and Hospital Settings Using Probudur describes how the company’s proprietary liposomal bupivacaine gel demonstrated the ability to provide post-operative pain control for up to 96 hours.
Another poster entitled “Enkephalin as a Potential Analgesic and CNS Modulator“ appeared at PAINWeek 2021. It shows that nanoparticle encapsulation of enkephalin would lead to effective brain delivery and analgesia.